Correction (DOI:10.1016/j.jpeds.2005.10.032);Duration of illness is an important variable for untreated children with juvenile dermatomyositis

Journal of Pediatrics

Volumn 148, Issue 2, 2006, Pages 247-253

  Pachman, Lauren M ^a   Abbott, Kathy ^b   Sinacore, James M ^b   Amoruso, Lisa ^b   Dyer, Alan ^b   Lipton, Rebecca ^b   Ilowite, Norman ^b   Hom, Christine ^b   Cawkwell, Gail ^b   White, Andrew ^b   Rivas Chacon, Rafael ^b   Kimura, Yukiko ^b   Ray, Linda ^b   Ramsey Goldman, Rosalind ^b  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; FRUCTOSE BISPHOSPHATE ALDOLASE; LACTATE DEHYDROGENASE; MUSCLE ENZYME;

ANTHROPOMETRY; ARTHRITIS; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOMYCOSIS; DISEASE ACTIVITY; DYSPHAGIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE; PHYSICIAN; PRIORITY JOURNAL; RASH; SCHOOL CHILD; SKIN; WEAKNESS;

EID: 33344455589     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2007.01.008     Document Type: Erratum

References (25)

1. E.P. Mendez, R.B. Lipton, A. Dyer, R. Ramsey-Goldman, P. Roettcher, S. Bowyer Incidence of juvenile dermatomyositis (JDM) 1995-98 results from the NIAMS Registry Arthritis Care Res 49 2003 300 305
2. A. Bohan, J.B. Peter Polymyositis and dermatomyositis, part 1 N Engl J Med 292 1975 344 347
3. L.M. Pachman, R.B. Lipton, R. Ramsey-Goldman, E. Shamiyeh, K. Abbott, E.P. Mendez History of infection before the onset of juvenile dermatomyositis (JDM) results from the National Institute of Arthritis, Muscle and Skin Diseases (NIAMS) Research Registry Arthritis Care Res 53 2005 166 172
4. R.K. Bode, M.S. Klein-Gitelman, M.L. Miller, T.S. Lechman, L.M. Pachman Disease activity score for children with juvenile dermatomyositis (JDM) reliability and validity evidence Arthritis Care Res 49 2003 7 15
5. R.L. Smith, J. Sundberg, E. Shamiyeh, A. Dyer, L.M. Pachman Skin involvement in juvenile dermatomyositis (JDM) is associated with loss of end row nailfold capillary (NFC) loops J Rheumatol 31 2004 1644 1649
6. C.D. Jordan, J.G. Flood, M. Laposata, K.B. Lewandrowski Normal reference laboratory values N Engl J Med 327 1992 718 724
7. N. Ruperto, A. Ravelli, K.J. Murray, D.J. Lovell, B. Andersson-Gare, B.M. Feldman Preliminary core sets of measures for disease activity and damage for juvenile systemic lupus erythematosus and juvenile dermatomyositis Rheumatology (Oxford) 42 2003 1452 1459
8. P.R. Yarnold, R.C. Soltysik Optimal data analysis a guidebook with software for Windows 2005 American Psychological Association Washington, DC
9. L.M. Pachman, J.R. Hayford, A. Chung, C.D. Daugherty, M.A. Pallansch, C.W. Fink Juvenile dermatomyositis at diagnosis clinical characteristics of 79 children J Rheumatol 25 1998 1198 1204
10. T.M. Peloro, O.F. Miller III, T.F. Hahn, E.D. Newman Juvenile dermatomyositis a retrospective review of a 30-year experience J Am Acad Derm 45 2001 28 34
11. M.A.J. Van Rossum, I. Hiemstra, A.M. Prieur, G.T. Rijkers, W. Kuis Juvenile dermato/polymositis a retrospective analysis of 33 cases with special focus on initial CPK levels Clin Exp Rheumatol 12 1994 339 342
12. D.P. Symmons, J.A. Sills, S.M. Davis The incidence of juvenile dermatomyositis results from a nationwide study Br J Rheumatol 34 1995 732 736
13. L.M. Pachman, J.R. Hayford, M.C. Hochberg, M.A. Pallansch, A. Chung, C.D. Daugherty New-onset juvenile dermatomyositis comparisons with a healthy cohort and children with juvenile rheumatoid arthritis Arthritis Rheum 40 1997 1526 1533
14. E.P. Hoffman, D. Rao, L.M. Pachman Clarifying the boundaries between inflammatory and dystrophic myopathies insights from molecular diagnostics and microarrays Rheum Dis Clin North Am 28 2002 743 757
15. Z. Tezak, E.P. Hoffman, J.L. Lutz, T.O. Fedczyna, D.A. Stephan, I. Krasnoselska Expression profiling in DQA1* (*)0501 children with juvenile dermatomyositis a novel model of pathogenesis J Immunol 168 2002 4154 4163
16. P.H. Plotz, L.G. Rider, I.N. Targoff, N. Raben, T.P. O'Hanlon, F.W. Miller NIH Conference Myositis immunologic contributions to understanding cause, pathogenesis, and therapy Ann Intern Med 122 1995 715 724
17. L.G. Rider, F.W. Miller Classification and treatment of the juvenile idiopathic inflammatory myopathies Rheum Dis Clin North Am 23 1997 619 655
18. E.A. Shamim, L.G. Rider, F.W. Miller Update on the genetics of the idiopathic inflammatory myopathies Curr Opin Immunol 12 2000 482 491
19. L.M. Pachman, M.R. Liotta-Davis, D.K. Hong, T.R. Kinsella, E.P. Mendez, J.M. Kinder TNF alpha-308A allele in juvenile dermatomyositis association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications Arthritis Rheum 43 2000 2368 2377
20. K.A. Rouster-Stevens, J.A. Daru, L.M. Pachman, B. Jovanovic, K.L. Ngai Pharmacokinetic study of oral prednisolone compared with intravenous methylprednisolone in patients with vasculitis of rheumatic disease Arthritis Rheum 50 Suppl 2004 S107
21. A.M. Huber, B. Lang, C.M. LeBlanc, N. Birdi, R.K. Bolaria, P. Malleson Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis Arthritis Rheum 43 2000 541 549
22. S.L. Bowyer, C.E. Blane, D.B. Sullivan, J.T. Cassidy Childhood dermatomyositis factors predicting functional outcome and development of dystrophic calcification J Pediatr 103 1983 882 888
23. L.M. Pachman, J.M. Friedman, M.C. Maryjowski, O. Jonasson, G.C. Sharp, M.A. Cobb Immunogenetic studies in juvenile dermatomyositis III study of antibody to organ-specific and nuclear antigens Arthritis Rheum 28 1985 151 157
24. L.M. Pachman, K. Abbott, Y.-W. Chen, L. Amoruso, J.M. Sinacore, C. Hom Duration of untreated JDM is a critical factor at diagnosis (DX) muscle enzyme concentration, disease activity score (DAS), dystrophic calcifications and muscle biopsy (MBX) gene expression profile data Arthritis Rheum 50 Suppl 2004 s107
25. M.A. Van Rossum, I. Hiemstra, A.M. Prieur, G.T. Rijkers, W. Kuis Juvenile dermato/polymyositis a retrospective analysis of 33 cases with special focus on initial CPK levels Clin Exp Rheumatol 12 1994 339 342